The BCMA Targeted Therapies Market is rapidly evolving, driven by significant advancements in the field of immunotherapy and the increasing prevalence of B-cell malignancies. B-cell maturation antigen (BCMA) has emerged as a crucial target for novel treatments, offering hope to patients with challenging diseases such as multiple myeloma. This article delves into the current state of the B-cell...